Feedback / Questions
deramiocel (CAP-1002) - Capricor, Lonza, Nippon Shinyaku
https://www.globenewswire.com/news-release/2025/03/17/3043799/0/en/Capricor-Therapeutics-Announces-Positive-Data-Demonstrating-Long-Term-Efficacy-of-Deramiocel-for-the-Treatment-of-Duchenne-Muscular-Dystrophy.html
Mar 17, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next